Agilent Technologies (A) Stock Price, Quote & News

Company Profile

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufact...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 800 227 9770

Website: www.agilent.com

Address:

5301 Stevens Creek Boulevard, Santa Clara, United States

mikesterz7 May. 19 at 2:27 PM

$A Agilent will roll out its Bulk Alarm Resolution Technology (BRT) at airport security checkpoints in FIFA World Cup host cities across the U.S. The system is designed to screen larger quantities of liquids, powders and solids, easing congestion during peak travel demand tied to the FIFA World Cup.

0 · Reply

StocktwitsNews May. 19 at 1:50 PM

Agilent Wins TSA Contract To Upgrade US Airport Security Ahead Of FIFA World Cup 2026 $A https://stocktwits.com/news/equity/markets/agilent-tsa-us-airport-security-upgrade-fifa-world-cup-2026/cZXuqzcReNG

0 · Reply

ArtemisArbitrage May. 15 at 10:08 AM

$A trying to stay on the winning side

0 · Reply

Estimize May. 6 at 2:39 PM

Wall St is expecting 1.41 EPS for $A Q2 [Reporting 05/27 AMC] http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=

0 · Reply

TalkMarkets May. 5 at 10:01 PM

3 Water #Stocks For Long-Term #Dividend Growth $BMI $A $ROP https://talkmarkets.com/article/3-water-stocks-for-long-term-dividend-growth-1778018424

0 · Reply

CapitalMonk May. 4 at 11:49 PM

$A Price: $112.18 (-2.04%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±1.44% RSI: 35.7 | Momentum: Strong Downside Volume: +3.8% vs avg Volatility: 2.18% Support: $110.31 | Resistance: $124.89 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25

0 · Reply

DakineKR Apr. 30 at 11:27 AM

$A how low does this sink, just feels anemic. Drifting to nowhere.

0 · Reply

harmongreg Apr. 21 at 5:47 PM

added $A May 125 calls

0 · Reply

TangibleOne Apr. 21 at 1:41 AM

$A Long here and SKM (ticker) for the Anthropic pre IPO exposure!!!!

0 · Reply

OnlyFibs Apr. 19 at 1:39 AM

$A — Agilent Technologies. $7.3–7.5B revenue guided for FY2026. Non-GAAP EPS $5.90–6.04. Book-to-bill above 1.0 for 8 consecutive quarters. Q1 revenue +7%, EPS +4%, guidance raised. 1W chart shows a 4-year symmetrical triangle at the apex — forced resolution approaching. RSI at lowest level since COVID crash. Weekly buy volume building. 🐂 Upper diagonal breaks → $129 → $137 → triangle target $150+ 🐻 China deteriorates + upper diagonal rejects → lower diagonal $108 → $102 ⚠️ 20x forward non-GAAP EPS on 7% revenue growth — historically cheap for Agilent. Triangle apex means the range-bound period ends. RSI and book-to-bill both bullish. #A #Agilent #LifeScience #hovdid

0 · Reply

Agilent to supply Bulk Alarm Resolution Technology to U.S. airport security

May 19, 2026, 8:00 AM EDT - 1 day ago

Agilent to Supply Next Generation Alarm Resolution Technology to U.S. Airport Security Screening Checkpoints ahead of FIFA World Cup 2026

May 11, 2026, 4:15 PM EDT - 8 days ago

Agilent to Participate in Jefferies Global Healthcare Conference

2026-05-04T12:32:30.000Z - 16 days ago

Agilent appoints Michael Buckner as CLO

DHR

May 4, 2026, 8:00 AM EDT - 16 days ago

Agilent Names Michael Buckner as Chief Legal Officer

Apr 28, 2026, 4:15 PM EDT - 21 days ago

Agilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27

2026-04-22T11:31:54.000Z - 4 weeks ago

Labcorp announces availability of Agilent’s PD-L1 IHC 22C3 pharmDx

LH MRK

Apr 21, 2026, 8:00 AM EDT - 4 weeks ago

Axion BioSystems and Agilent Technologies Resolve Litigation

2026-04-15T12:24:06.000Z - 5 weeks ago

Agilent showcases cancer research solutions at AACR 2026

Apr 15, 2026, 8:00 AM EDT - 5 weeks ago

Agilent Showcases Cancer Research Solutions at AACR 2026

2026-04-14T10:50:16.000Z - 5 weeks ago

Agilent price target lowered to $140 from $150 at Barclays

2026-04-06T12:10:20.000Z - 6 weeks ago

Agilent price target lowered to $140 from $160 at Evercore ISI

2026-04-01T12:07:47.000Z - 7 weeks ago

Agilent announces BioTek Cytation 9 cell imaging multimode reader

Apr 1, 2026, 8:00 AM EDT - 7 weeks ago

Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader

Mar 27, 2026, 7:00 AM EDT - 7 weeks ago

Agilent Technologies Slides: Corporate presentation

2026-03-26T12:05:50.000Z - 7 weeks ago

Agilent receives FDA approval for PD-L1 1HC 22C3 pharmDx

MRK

Mar 26, 2026, 8:00 AM EDT - 7 weeks ago

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma

2026-03-26T11:15:53.000Z - 7 weeks ago

Agilent upgraded to Buy from Hold at Nephron Research

Mar 19, 2026, 8:00 AM EDT - 2 months ago

Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026

Mar 11, 2026, 8:00 AM EDT - 2 months ago

Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States

2026-03-11T09:55:11.000Z - 2 months ago

Citi opens ‘upside 90-day catalyst watch’ on Agilent

2026-03-09T09:20:45.000Z - 2 months ago

Agilent to acquire Biocare Medical for $950M in cash

2026-03-09T08:29:21.000Z - 2 months ago

M&A News: Agilent to Buy Biocare Medical for $950M — What Investors Should Know

Mar 9, 2026, 3:09 AM EDT - 2 months ago

Agilent to acquire Biocare Medical in $950 million all-cash deal

Mar 9, 2026, 3:05 AM EDT - 2 months ago

Excellere Partners and GHO Capital Sell Biocare Medical to Agilent Technologies

Mar 9, 2026, 3:00 AM EDT - 2 months ago

Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions

Mar 3, 2026, 11:10 AM EST - 2 months ago

Agilent Technologies Transcript: TD Cowen 46th Annual Health Care Conference

2026-03-03T13:08:32.000Z - 2 months ago

Agilent price target lowered to $160 from $180 at Morgan Stanley

2026-02-26T23:55:19.000Z - 2 months ago

Agilent price target lowered to $150 from $170 at Goldman Sachs

2026-02-26T15:15:36.000Z - 2 months ago

Agilent price target lowered to $155 from $165 at Baird

2026-02-26T14:24:46.000Z - 2 months ago

Agilent price target lowered to $157 from $170 at TD Cowen

2026-02-26T13:18:20.000Z - 2 months ago

Agilent price target lowered to $165 from $180 at UBS

2026-02-26T10:10:48.000Z - 2 months ago

Agilent price target lowered to $150 from $165 at Barclays

Feb 25, 2026, 5:24 PM EST - 2 months ago

Agilent reports in-line first quarter, says results hurt by US snowstorm

Feb 25, 2026, 4:30 PM EST - 2 months ago

Agilent Technologies Earnings Call Transcript: Q1 2026

Feb 25, 2026, 4:30 PM EST - 2 months ago

Agilent Technologies Quarterly report: Q1 2026

Feb 25, 2026, 4:30 PM EST - 2 months ago

Agilent Technologies Earnings release: Q1 2026

Feb 25, 2026, 4:30 PM EST - 2 months ago

Agilent Technologies Slides: Q1 2026

Feb 25, 2026, 4:05 PM EST - 2 months ago

Agilent Reports First-Quarter Fiscal Year 2026 Financial Results

Feb 23, 2026, 4:15 PM EST - 3 months ago

Agilent to Participate in TD Cowen's 46th Annual Health Care Conference

Feb 11, 2026, 4:15 PM EST - 3 months ago

Agilent Announces Cash Dividend of 25.5 Cents per Share

Feb 11, 2026, 8:00 AM EST - 3 months ago

Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award

Feb 11, 2026, 6:45 AM EST - 3 months ago

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)

Feb 6, 2026, 7:00 AM EST - 3 months ago

Agilent Technologies Proxy statement: Proxy Filing

Feb 6, 2026, 7:00 AM EST - 3 months ago

Agilent Technologies Proxy statement: Proxy Filing

Feb 4, 2026, 8:00 AM EST - 3 months ago

Agilent Showcases Next‑Generation Automated Solutions at SLAS2026

Feb 2, 2026, 4:15 PM EST - 3 months ago

Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25

Jan 23, 2026, 8:00 AM EST - 4 months ago

Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System

Jan 23, 2026, 7:00 AM EST - 4 months ago

Agilent Technologies Proxy statement: Proxy Filing

Jan 13, 2026, 12:00 PM EST - 4 months ago

Agilent Technologies Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 12:00 PM EST - 4 months ago

Agilent Technologies Slides: 44th Annual J.P. Morgan Healthcare Conference

Dec 16, 2025, 8:31 AM EST - 5 months ago

Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 4, 2025, 9:00 AM EST - 5 months ago

Agilent Technologies Transcript: Citi Annual Global Healthcare Conference 2025

Dec 1, 2025, 8:00 AM EST - 6 months ago

Agilent Announces 21 CFR Part 11 Compliance Software for xCELLigence RTCA eSight

Nov 25, 2025, 1:24 PM EST - 6 months ago

Top small-cap plays for 2026

COHR DG EW TXT VLO

Nov 24, 2025, 4:30 PM EST - 6 months ago

Agilent Technologies Earnings Call Transcript: Q4 2025

Nov 24, 2025, 4:30 PM EST - 6 months ago

Agilent Technologies Annual report: Q4 2025

Nov 24, 2025, 4:30 PM EST - 6 months ago

Agilent Technologies Earnings release: Q4 2025

Nov 24, 2025, 4:30 PM EST - 6 months ago

Agilent Technologies Slides: Q4 2025

Nov 24, 2025, 4:10 PM EST - 6 months ago

Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results

Nov 24, 2025, 4:07 PM EST - 6 months ago

Agilent beats quarterly revenue estimates on strong demand for lab tools

Nov 24, 2025, 1:50 PM EST - 6 months ago

Josh Brown's ‘best stocks in the market': Health Care

LLY MTD TMO XLV

Nov 19, 2025, 4:15 PM EST - 6 months ago

Agilent Announces Cash Dividend of 25.5 Cents Per Share

Nov 18, 2025, 5:10 PM EST - 6 months ago

Agilent to Participate in Citi's 2025 Global Healthcare Conference

Nov 12, 2025, 8:00 AM EST - 6 months ago

Agilent Research Catalyst (ARC) Award Presented to UC Davis for Breakthroughs in Peptide Therapeutics

Oct 30, 2025, 4:15 PM EDT - 7 months ago

Agilent to Announce Fourth-Quarter Fiscal Year 2025 Financial Results on Nov. 24

Oct 27, 2025, 4:15 PM EDT - 7 months ago

Agilent Names Adam S. Elinoff as Chief Financial Officer

Sep 30, 2025, 8:00 AM EDT - 8 months ago

Agilent Announces New Insight Series Alarm Resolution Systems for Airport Security Screening

Sep 30, 2025, 7:00 AM EDT - 8 months ago

Agilent Technologies Slides: Investor Presentation

Sep 29, 2025, 8:00 AM EDT - 8 months ago

Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing

Sep 25, 2025, 4:50 AM EDT - 8 months ago

Agilent Technologies Transcript: Bank of America Global Healthcare Conference 2025

Sep 22, 2025, 9:00 AM EDT - 8 months ago

Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine

Sep 17, 2025, 4:05 PM EDT - 8 months ago

Agilent Announces Cash Dividend of 24.8 Cents per Share

Sep 11, 2025, 4:15 PM EDT - 8 months ago

Agilent to Participate in 2025 Bank of America Global Healthcare Conference

Sep 9, 2025, 8:00 AM EDT - 9 months ago

Agilent Refurbishment Centers Achieve Top-Level My Green Lab Certification

Sep 8, 2025, 4:30 PM EDT - 9 months ago

Agilent (A) CEO on PFAS Testing Growth & Creating Advanced Instruments for Science

Sep 3, 2025, 11:00 AM EDT - 9 months ago

Agilent Technologies Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Sep 3, 2025, 8:00 AM EDT - 9 months ago

Agilent to Showcase New Dako Omnis Family at European Congress of Pathology 2025

Sep 2, 2025, 8:00 AM EDT - 9 months ago

Agilent's MMR IHC Panel pharmDx (Dako Omnis) Receives European IVDR Certification as a Companion Diagnostic Test for Colorectal Cancer

Aug 27, 2025, 4:30 PM EDT - 9 months ago

Agilent Technologies Earnings Call Transcript: Q3 2025

Aug 27, 2025, 4:30 PM EDT - 9 months ago

Agilent Technologies Quarterly report: Q3 2025

Aug 27, 2025, 4:30 PM EDT - 9 months ago

Agilent Technologies Earnings release: Q3 2025

Aug 27, 2025, 4:30 PM EDT - 9 months ago

Agilent Technologies Slides: Q3 2025

Aug 27, 2025, 4:05 PM EDT - 9 months ago

Agilent Reports Third-Quarter Fiscal Year 2025 Financial Results

Aug 27, 2025, 4:03 PM EDT - 9 months ago

Life sciences firm Agilent raises annual revenue outlook

Aug 26, 2025, 6:42 PM EDT - 9 months ago

Analysts Love These 3 Companies Reporting Earnings This Week

ADSK COO

Aug 21, 2025, 4:15 PM EDT - 9 months ago

Agilent to Participate in 2025 Wells Fargo Healthcare Conference

Aug 20, 2025, 8:00 AM EDT - 9 months ago

Agilent MMR IHC Panel pharmDx (Dako Omnis) Receives FDA Approval as a Companion Diagnostic Test for Colorectal Cancer

Aug 13, 2025, 8:00 AM EDT - 10 months ago

Shane Snyder to Lead New Agilent Center of Excellence at Georgia Tech Focused on Water and the Environment

Aug 4, 2025, 8:00 AM EDT - 10 months ago

Agilent Expands the Dako Omnis Family with Three New Models to Meet Evolving Pathology Lab Needs

mikesterz7 May. 19 at 2:27 PM

0 · Reply

StocktwitsNews May. 19 at 1:50 PM

0 · Reply

ArtemisArbitrage May. 15 at 10:08 AM

$A trying to stay on the winning side

0 · Reply

Estimize May. 6 at 2:39 PM

Wall St is expecting 1.41 EPS for $A Q2 [Reporting 05/27 AMC] http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=

0 · Reply

TalkMarkets May. 5 at 10:01 PM

3 Water #Stocks For Long-Term #Dividend Growth $BMI $A $ROP https://talkmarkets.com/article/3-water-stocks-for-long-term-dividend-growth-1778018424

0 · Reply

CapitalMonk May. 4 at 11:49 PM

0 · Reply

DakineKR Apr. 30 at 11:27 AM

$A how low does this sink, just feels anemic. Drifting to nowhere.

0 · Reply

harmongreg Apr. 21 at 5:47 PM

added $A May 125 calls

0 · Reply

TangibleOne Apr. 21 at 1:41 AM

$A Long here and SKM (ticker) for the Anthropic pre IPO exposure!!!!

0 · Reply

OnlyFibs Apr. 19 at 1:39 AM

0 · Reply

NorthStarStats Apr. 15 at 9:57 AM

Output from a custom NorthStarStats momentum scanner highlighting stocks with strengthening price structure and momentum. Setups to watch and study — not trade recommendations. $LEGN Score 100, $SLN Score 100, $A Score 100, $IMVT Score 98, $CG Score 95

0 · Reply

SuperGreenToday Apr. 8 at 2:12 PM

$A Share Price: $117.14 Contract Selected: Aug 21, 2026 $115 Calls Buy Zone: $9.27 – $11.45 Target Zone: $15.80 – $19.32 Potential Upside: 61% ROI Time to Expiration: 134 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

WhaleAndState Apr. 6 at 10:10 AM

$A filed an 8-K amendment — stock at $115.48, market cap $32.7B. The filing contains no material detail beyond the headline. Expect continued upward movement as market sentiment remains positive.

0 · Reply

Estimize Mar. 25 at 3:01 PM

Wall St is expecting 1.41 EPS for $A Q2 [Reporting 05/26 AMC] http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=

0 · Reply

Zefram Mar. 21 at 12:14 AM

$TTOO $A rip all those theories of options insider trading from trash camp... lul.. does that guy get anything right? being punished by losing all his money isn't enough to make him a humbled man... the guy has zero shame. this website is filled with entertainment... and he's like karl malone... he always delivers.

0 · Reply

Zefram Mar. 19 at 10:36 PM

$TTOO $A i trade 0 dte options almost every day.. i've probably made more money trading in the last month than you have all decade. i like how you haven't made money trading.. but some how you think you're better at this than me... LOL you're goofy bro. i walked you through TTOO and somehow you still lost your entire retirement. literally play by play... made it easy for you... and you still lost hundreds of thousands. what a moron. LOL

0 · Reply

Zefram Mar. 19 at 10:34 PM

$TTOO $A isn't it funny that you're on the side of the bagholders.... the masses of bagholders... and they barely interact with your posts too? you'd expect people to not interact or even see my posts.. guys like you block and put your head in the sand. what's your excuse? the only one who actually do interact with yours are other guys who lost everything and are incompetent in the trades like you are.. good way to farm those guys, bro.. birds of a feather. no one respectable or knowledgeable is interacting with your posts. LOL

0 · Reply

Zefram Mar. 19 at 10:14 PM

$TTOO $A what do you call it when you ride a stock down 99.9999%... and keep putting money into it? not dumb? lul k. you could forgive year 1.... but you'd like at year 5 or 6.. or 7... you'd learn from it. but you didnt. LOL that's not dumb? k, bro.

1 · Reply

Zefram Mar. 19 at 10:13 PM

$TTOO $A hint: it's not insider trading... it's never been insider trading... it's never been fraud. you just suck at analysis. that's why you keep losing. and you're port is nuked.

0 · Reply

Market Cap	31.68B
Revenue (ttm)	6.95B
Net Income (ttm)	1.30B
EPS (ttm)	N/A
PE Ratio	19.84
Forward PE	18.78
Profit Margin	18.75%
Debt to Equity Ratio	0.44

Volume	3,142,700
Avg Vol	2,011,102
Day's Range	N/A - N/A
Shares Out	282.60M
Stochastic %K	4%
Beta	1.22
Analysts	Strong Sell
Price Target	$162.64